Bio-Techne Corp (NAS:TECH)
$ 83.805 0.965 (1.16%) Market Cap: 13.21 Bil Enterprise Value: 13.56 Bil PE Ratio: 66.51 PB Ratio: 6.55 GF Score: 92/100

Bio-Techne Corp at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 02:10PM GMT
Release Date Price: $97 (+6.67%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. Welcome to Day 3 of our healthcare conference. Luke Sergott, I cover life science tools and diagnostics here at Barclays. I have the pleasure of Bio-Techne management team, Chuck Kummeth; Jim Hippel; and et al with us. I think they're going to give a little overview, a couple of sentences or background, and we're just going to dive right in.

Charles R. Kummeth
Bio-Techne Corporation - CEO, President & Director

All right. David is going to run some slides here. It's always interesting to do these virtual. I never know if I'm talking to 5 people or 5,000, but we'll pretend it's 1,000. Okay. So this is Bio-Techne, a 43-year-old company now. Here is our usual disclaimer. We won't waste any time on this. Everybody knows what this here is about. Move on.

So what are we about? So we recently touched $16 billion, but roughly $14 billion of a market cap company now. We're a fiscal company. So as of last June, we were $739, we're blowing that number out

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot